The REPOSE trial
The Relative Effectiveness of Pumps over MDI and Structured Education for Type-1 diabetes (REPOSE)
People with type 1 diabetes (T1DM) need insulin therapy to sustain life.
The most common treatment is injecting insulin several times a day. Another approach uses insulin pumps, the size of mobile phones, which are attached under the skin through fine tubing and which provide small amounts of insulin.
In the UK, pumps are recommended for people struggling to control their diabetes with injections, and are used far less often than in other countries.
Previous trials of pumps have been small and of short duration, and have failed to control for training in flexible insulin therapy.
The REPOSE trial aimed to assess the clinical effectiveness and cost-effectiveness of pump therapy compared with MDI for a wider population of adults with T1DM, with both groups receiving equivalent structured training in flexible insulin therapy.
We undertook a pragmatic cluster randomised controlled trial involving 267 people with T1DM in eight secondary care centres across England and Scotland.
Participants were allocated a place on a week-long educational course (DAFNE, Dose Adjustment For Normal Eating) to learn about flexible insulin therapy.
Course groups were then randomly allocated into two groups: one group also received training on how to use a pump to deliver their insulin while the second group used multiple insulin injections, for two years.
The primary outcome was change in HbA1c (a standard surrogate measure of glycaemic control) at two years, in those participants who had a baseline HbA1c of ≥7.5%.
We also collected data at 6, 12 and 24 months on episodes of moderate and severe hypoglycaemia, biochemical outcomes and diabetic ketoacidosis.
Quality of life data were collected using participant self-completed questionnaires and qualitative interviews were undertaken with participants and staff to aid interpretation of the findings. The trial also included a cost-effectiveness analysis.
Our results showed that both groups improved diabetes control after training. Participants using pumps had slightly better control, but differences were small (HbA1c was 0.24% lower than in the injections group).
We found that pumps were not cost-effective, although people using pumps reported better satisfaction with their treatment and in some aspects of their quality of life.
Our study suggests that making insulin pumps more widely available before structured training is unlikely to improve diabetes control or be cost-effective. Providing structured education to more people could be highly beneficial, with pumps made available to those needing better ways of delivering insulin to reach glucose targets.
The results have been provided to NICE. Our main recommendations were that although these data don’t directly affect NICE pump guidance since participants in REPOSE weren’t those currently those recommended for pump therapy, NICE should consider:
- The guideline on structured education is reinforced. Unfortunately this guidance has been poorly implemented and most patients with type 1 diabetes have not been offered evidence-based structured education.
However NICE guidance currently highlights the importance of DAFNE as a high quality structured education programme in type 1 diabetes and NHS England has recently provided funding for greater provision to patients.
- The new HbA1c target in the updated type 1 guideline, coupled with the need to avoid hypoglycaemia, will probably need increased use of CSII, particularly those highly active in their own management.
There is also a need to review the switching threshold of HbA1c of 8.5% in TA 151.
The REPOSE Study Group. Relative effectiveness of insulin pump treatment over multiple daily injections and structured education during flexible intensive insulin treatment for type 1 diabetes: cluster randomised trial (REPOSE). BMJ 2017;356:j1285.
Pollard DJ, Brennan A, Dixon S, Waugh N, Elliott J, Heller S, Lee E, Campbell M, Basarir H & White D (in press). The cost-effectiveness of insulin pumps compared to multiple daily injections, both provided with structured education, for adults with type 1 diabetes: a health economic analysis of the relative effectiveness of pumps over structured education (REPOSE) randomised controlled trial. BMJ Open. View this article in WRRO
White D, Waugh N, Elliott J, Lawton J, Barnard K, Campbell MJ, et al. The Relative Effectiveness of Pumps Over MDI and Structured Education (REPOSE): study protocol for a cluster randomised controlled trial. BMJ Open 2014;4:e006204. http://dx.doi.org/10.1136/bmjopen-2014-006204
Lawton J, Kirkham J, Rankin D, Barnard K, Cooper CL, Taylor C, et al. Perceptions and experiences of using automated bolus advisors amongst people with type 1 diabetes: a longitudinal qualitative investigation. Diabetes Res Clin Pract 2014;106:443–50. http://dx.doi.org/10.1016/j.diabres.2014.09.011
Lawton J, Kirkham J, White D, Rankin D, Cooper C, Heller S. Uncovering the emotional aspects of working on a clinical trial: a qualitative study of the experiences and views of staff involved in a type 1 diabetes trial. Trials 2015;16:3.
|School of Medicine,
University of Sheffield
|+44 (0)114 271 firstname.lastname@example.org|
Director of CTRU
|ScHARR||+44 (0)114 22 email@example.com|
|ScHARR||+44 (0)114 22 firstname.lastname@example.org|
|ScHARR||+44 (0)114 22 email@example.com|
|ScHARR||+44 (0)114 22 firstname.lastname@example.org|
Trials Support Officer
|ScHARR||+44 (0)114 22 email@example.com|
|ScHARR||+44 (0)114 22 firstname.lastname@example.org|
|ScHARR||+44 (0) 114 22 email@example.com|
|ScHARR||+44 (0)114 22 firstname.lastname@example.org|
|ScHARR||+44 (0) 114 222 email@example.com|
Professor of Health Economics
|ScHARR||+44 (0)114 22 firstname.lastname@example.org|
|ScHARR||+44 (0)114 22 email@example.com|
Professor of Health Economics and Decisions Modelling
|ScHARR||+44 (0)114 22 firstname.lastname@example.org|
|ScHARR||+44 (0)114 22 email@example.com|
|Dr Kath Barnard
Psychosocial Quantitative Research Fellow
|University of Southampton||+ 44 (0) 2380 595548||K.Barnard@soton.ac.uk|
|Dr Julia Lawton
Qualitative Psychosocial Research Fellow
|University of Edinburgh||+44 (0) 1316 firstname.lastname@example.org|
|Professor Norman Waugh
Deputy Chief Investigator
|University of Warwickemail@example.com|
National DAFNE director
|Central DAFNE||+44 (0) 1912 firstname.lastname@example.org|
|Centre name||Principal Investigator||Educators- DSNs and dieticians|
|Sheffield Teaching Hospitals NHS Foundation Trust||Simon Heller
Co-investigator: Jackie Elliott
|Addenbrookes Hospital, Cambridge||Mark Evans
Co-investigator: Leila Faghahati
Kulbir Kaur Pabla
|Harrogate District Hospital||Peter Hammond
Co-investigator: Sutapa Ray
|King’s College Hospital, London||Stephanie Amiel
Co-investigator: Pratik Choudhary
|Dumfries and Galloway Royal Infirmary||
|Glasgow Royal Infirmary||Robert Lindsay
Co-investigator: Brian Kennon
|Royal Infirmary of Edinburgh||Alan Jaap
Co-investigator: Alan Patrick
|Nottingham University Hospitals NHS Trust||Peter Mansell
Co-investigator: Tasso Gazis
The University’s four flagship institutes bring together our key strengths to tackle global issues, turning interdisciplinary and translational research into real-world solutions.